[Olanzapine as an alternative in clozapine-induced akathisia?].
Knoch
H
H
Psychiatrische Universitätsklinik, Basel.
Hofmann
M
M
Seifritz
E
E
D000328:Adult; D017109:Akathisia, Drug-Induced / Q000209:etiology*; D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D016651:Lithium Carbonate / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
D018692:Antimanic Agents; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D016651:Lithium Carbonate; D010890:Pirenzepine; D003024:Clozapine; D000077152:Olanzapine